Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer

Name: Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer
License: Public Domain

Dwight Owen

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

grade i neuroendocrine carcinoma, grade ii neuroendocrine carcinoma, grade iii neuroendocrine carcinoma, metastatic neuroendocrine carcinoma, neuroendocrine carcinoma, recurrent small cell lung carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 442092
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.